Diffuse large B-cell lymphoma trials, also abroad
346 open Diffuse large B-cell lymphoma trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Country | Open trials |
|---|---|
| United States | 131 |
| Italy | 34 |
| France | 26 |
| Spain | 24 |
| Australia | 20 |
| South Korea | 18 |
| Canada | 16 |
| Poland | 15 |
| Germany | 14 |
| United Kingdom | 13 |
| Belgium | 10 |
| Netherlands | 9 |
54 more countries
Brazil 8, Denmark 8, Israel 8, Japan 8, Greece 7, Sweden 7, Türkiye 7, Taiwan 7, Czechia 6, Austria 5, Switzerland 5, Hungary 5, Portugal 5, Chile 4, Mexico 4, New Zealand 4, Romania 4, Ukraine 4, Argentina 3, Colombia 3, Egypt 3, Finland 3, Hong Kong 3, Croatia 3, Ireland 3, Moldova 3, Thailand 3, Bulgaria 2, Georgia 2, Guatemala 2, India 2, Lithuania 2, Malaysia 2, Norway 2, Peru 2, Puerto Rico 2, Russia 2, Singapore 2, United Arab Emirates 1, Costa Rica 1, Estonia 1, Iraq 1, Jordan 1, Kuwait 1, Lebanon 1, Morocco 1, Oman 1, Pakistan 1, Qatar 1, Serbia 1, Saudi Arabia 1, Slovenia 1, Slovakia 1, South Africa 1
The same trial often runs in several countries
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010): 24 sites in China, 35 countries in all. If a site near you is full, another one may still take people.
See this trial in all 35 countriesAll Diffuse large B-cell lymphoma trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.